Eye injections could clear Diabetes-Related bleeding and save sight

NCT ID NCT07690800

Completed Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether injections of ranibizumab, a drug that blocks abnormal blood vessel growth, can help clear bleeding inside the eye in people with diabetes. The bleeding, called diabetic vitreous hemorrhage, can blur or block vision. Participants receive the injection and are followed for 3 to 6 months to see if their vision improves, the bleeding clears, and whether they can avoid more invasive surgery. The trial includes adults aged 20 to 70 with diabetes-related eye bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ranibizumab (Lucentis)
What this could lead to: If it works, this could offer a less invasive way to clear bleeding in the eye from diabetes, potentially saving vision and avoiding surgery.
What could go wrong: This is a small, early-phase study with only 30 participants, so results may not apply to everyone. Risks include eye infection, inflammation, or the bleeding not clearing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates